PTGS1 rs5789: Understanding This Genetic Variant
The rs5789 variant is a polymorphism located within the PTGS1 gene, which encodes the cyclooxygenase-1 enzyme. Researchers investigate this variant for potential associations with aspirin response and cardiovascular event risk.
What each genotype means
Typical PTGS1 genotype
This genotype represents the most common variation observed in many populations for this specific site in the PTGS1 gene. Research into this variant has explored its potential role in aspirin response and cardiovascular health, but current evidence remains limited and mixed regarding its clinical impact. Please discuss any concerns regarding medication response or cardiovascular risk with your healthcare provider.
This is the most common genotype for this variant in most studied populations.
Common variant carrier
Carrying one copy of the C allele is a common finding in many populations. While this variant in the PTGS1 gene has been investigated for associations with aspirin intolerance and cardiovascular event risk, the scientific evidence is not definitive. You should consult with your clinician or pharmacist regarding any questions about medication dosing or cardiovascular health.
This heterozygous genotype is found at moderate frequencies across various global populations.
Less common variant genotype
This genotype represents the less common variation at this position in the PTGS1 gene. Although this variant has been studied in the context of aspirin sensitivity and cardiovascular outcomes, the clinical significance remains unclear and requires further research. Always discuss your personal health history and medication needs with a qualified medical professional.
This genotype is less common than the A/A or A/C genotypes, with a global minor allele frequency reported around 1.7%.
What is the rs5789 Variant?
The rs5789 variant is a specific single nucleotide polymorphism (SNP) found within the PTGS1 gene. In genomics, a SNP represents a variation at a single position in the DNA sequence among individuals. The PTGS1 gene is located on chromosome 9 and provides instructions for creating the cyclooxygenase-1 (COX-1) enzyme. This enzyme plays a critical role in the body by converting arachidonic acid into prostaglandins, which are lipid compounds that act as signaling molecules. Because rs5789 is situated within this gene, scientists study it to determine if it influences the structure, expression, or function of the COX-1 protein. Understanding such variants is a primary focus of pharmacogenomics, a field that examines how an individual's genetic makeup can influence their response to medications, including common anti-inflammatory drugs.
The Role of the PTGS1 Gene
The PTGS1 gene is essential for maintaining various physiological processes, particularly those requiring continuous regulation. The COX-1 enzyme it produces is expressed constitutively, meaning it is produced at a steady rate in many tissues, such as the stomach lining and platelets. In platelets, COX-1 is responsible for the production of thromboxane A2, a substance that promotes blood clotting. Because of this, PTGS1 is a major target for nonsteroidal anti-inflammatory drugs (NSAIDs) like aspirin. Aspirin works by irreversibly inhibiting the cyclooxygenase activity of the COX-1 enzyme, which reduces the production of thromboxane and thereby inhibits platelet aggregation. This mechanism is why aspirin is frequently used to help prevent cardiovascular events like heart attacks and strokes in at-risk populations.
Research and Clinical Associations
Research into PTGS1 variants, including rs5789, often focuses on whether genetic differences contribute to 'aspirin resistance' or variability in how well aspirin prevents blood clots. Some studies have explored whether specific polymorphisms in PTGS1 are associated with an increased risk of cardiovascular events or differences in how patients respond to antiplatelet therapy. However, the evidence regarding rs5789 specifically is limited and often mixed. While some studies in the broader field of pharmacogenomics suggest that genetic variation in PTGS1 may modify disease risk or drug response, these findings are frequently population-specific or require larger, more diverse cohorts to confirm. It is important to note that cardiovascular health is influenced by a complex interplay of many genes, environmental factors, and lifestyle choices, rather than a single genetic variant.
Population Frequency and Interpretation
The rs5789 variant is considered common across many global populations. In genetic studies, 'common' typically means that the variant is found at a significant frequency in the general population, rather than being a rare mutation. Because it is common, it is frequently included in large-scale genomic association studies. When interpreting information about this variant, it is crucial to understand that having a specific genotype does not equate to a medical diagnosis or a guaranteed clinical outcome. Genetic data provides a piece of the puzzle regarding biological variability, but it does not replace clinical evaluation. If you are concerned about how your genetics might influence your response to aspirin or other medications, you should discuss this with your healthcare provider or a clinical pharmacist who can interpret your health history in the context of current medical guidelines.
How common is this variant?
The rs5789 variant is common in many populations worldwide, with its specific allele frequencies varying across different ancestral groups.
Frequently asked questions
Does the rs5789 variant mean I am resistant to aspirin?
No, having this variant does not automatically mean you are resistant to aspirin. Aspirin response is complex and influenced by many factors, including other genes, diet, and underlying health conditions.
Should I change my medication based on my PTGS1 genotype?
You should never change your medication or dosage based on genetic test results without consulting your doctor. Always speak with your clinician or pharmacist before making any changes to your prescribed treatment plan.
Is PTGS1 rs5789 a cause of heart disease?
There is no evidence that this variant is a direct cause of heart disease. While researchers study it for potential associations with cardiovascular risk, heart disease is a multifactorial condition influenced by many genetic and environmental factors.
Where can I find more information about PTGS1?
You can find reliable information about the PTGS1 gene and its function through resources like MedlinePlus Genetics, the NCBI Gene database, and UniProt. These databases provide comprehensive, peer-reviewed summaries of gene function and known variants.
Sources & further reading
Educational information only, last refreshed 9/27/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs5789?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29